Abstract
This study set out to access the performance of quantitative analysis of contrast-enhanced ultrasound (CEUS) indistinguishing between benign periablational enhancement (BPE) and residual tumor (RT) following radiofrequency ablation(RFA). 165 tumors from 124 patients with hepatocellular carcinoma between 2021 and 2023underwent RFA, contrast-enhanced computed tomography (CECT), and CEUS in less than 24 hours. Analysis was done onthe quantitative parameters from RT and BPE found by CEUS. Complete ablation was obtained in 89.1% of lesions.When compared to BPE, RT had significantly greater peak intensity (PI), time to peak (TTP), area under the curve (AUC),ratio of PI and base intensity (PI/BI), and enhanced intensity (EI) values (all p<0.05). PI, TTP, AUC, PI/BI, and EI had largeareas under the receiver operating (ROC) curves. A binary logistic regression analysis, respectively, demonstrated that PI andPI/BI were independent favorable prognostic variables. Multiple parameters of quantitative analysis of CEUScan aid in distinguishing immediately between RT and BPE lesions. PI and PI/BI may be a more promising parameter. ImmediateCEUS evaluation following RFA may allow immediate retreatment of RT during the same operation time, which reducespatients' hospital stays and financial costs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call